Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1995 Jun;48(6):501–508. doi: 10.1136/jcp.48.6.501

Routine and specialised techniques in the diagnosis of haematological neoplasms.

B J Bain 1
PMCID: PMC502677  PMID: 7665691

Abstract

The relative importance of traditional techniques used in the diagnosis of haematological neoplasms has altered during the past decade. Cytology and histology retain their central role but the importance of cytochemistry has declined, except in the diagnosis of AML. Immunophenotyping is of major importance in the diagnosis of ALL, some categories of AML and the LPDs. Cytogenetic and molecular genetic analysis are important in the diagnosis of CML and are becoming increasingly important in the diagnosis of chronic LPDs and other haematological neoplasms. Diagnostic haematology laboratories which are not specialist leukaemia centres should have ready access to all of these techniques to ensure optimal patient management. However, not all techniques need to be performed in every laboratory.

Full text

PDF
501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bain B. J., Catovsky D. The leukaemic phase of non-Hodgkin's lymphoma. J Clin Pathol. 1995 Mar;48(3):189–193. doi: 10.1136/jcp.48.3.189. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bain B., Catovsky D. Current concerns in haematology. 2: Classification of acute leukaemia. J Clin Pathol. 1990 Nov;43(11):882–887. doi: 10.1136/jcp.43.11.882. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Barrett A. J. Bone marrow transplantation for acute lymphoblastic leukaemia. Baillieres Clin Haematol. 1994 Jun;7(2):377–401. doi: 10.1016/s0950-3536(05)80209-4. [DOI] [PubMed] [Google Scholar]
  4. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposal for the recognition of minimally differentiated acute myeloid leukaemia (AML-MO) Br J Haematol. 1991 Jul;78(3):325–329. doi: 10.1111/j.1365-2141.1991.tb04444.x. [DOI] [PubMed] [Google Scholar]
  5. Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A., Gralnick H. R., Sultan C. Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group. J Clin Pathol. 1989 Jun;42(6):567–584. doi: 10.1136/jcp.42.6.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Cervantes F., Robertson J. E., Rozman C., Baccarani M., Tura S., Gómez G. A., Braun T. J., Clarkson B. D., Pereira A. Long-term survivors in chronic granulocytic leukaemia: a study by the International CGL Prognosis Study Group. Italian Cooperative CML Study Group. Br J Haematol. 1994 Jun;87(2):293–300. doi: 10.1111/j.1365-2141.1994.tb04912.x. [DOI] [PubMed] [Google Scholar]
  7. Crist W. M., Carroll A. J., Shuster J. J., Behm F. G., Whitehead M., Vietti T. J., Look A. T., Mahoney D., Ragab A., Pullen D. J. Poor prognosis of children with pre-B acute lymphoblastic leukemia is associated with the t(1;19)(q23;p13): a Pediatric Oncology Group study. Blood. 1990 Jul 1;76(1):117–122. [PubMed] [Google Scholar]
  8. Demory J. L., Dupriez B., Fenaux P., Laï J. L., Beuscart R., Jouet J. P., Deminatti M., Bauters F. Cytogenetic studies and their prognostic significance in agnogenic myeloid metaplasia: a report on 47 cases. Blood. 1988 Sep;72(3):855–859. [PubMed] [Google Scholar]
  9. Hann I. M., Eden O. B., Barnes J., Pinkerton C. R. 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. United Kingdom Children's Cancer Study Group (UKCCSG). Br J Haematol. 1990 Nov;76(3):359–364. doi: 10.1111/j.1365-2141.1990.tb06368.x. [DOI] [PubMed] [Google Scholar]
  10. Hoyle C. F., Gray R. G., Wheatley K., Swirsky D., de Bastos M., Sherrington P., Rees J. K., Hayhoe F. G. Prognostic importance of Sudan Black positivity: a study of bone marrow slides from 1,386 patients with de novo acute myeloid leukaemia. Br J Haematol. 1991 Nov;79(3):398–407. doi: 10.1111/j.1365-2141.1991.tb08047.x. [DOI] [PubMed] [Google Scholar]
  11. Invernizzi R., Iannone A. M., Bernuzzi S., D'Alessio A., Fiamenghi C., Ippoliti G., Scagliosi S., Ascari E. Acute promyelocytic leukemia: morphological and clinical features. Haematologica. 1993 May-Jun;78(3):156–161. [PubMed] [Google Scholar]
  12. Kantarjian H. M., Kurzrock R., Talpaz M. Philadelphia chromosome-negative chronic myelogenous leukemia and chronic myelomonocytic leukemia. Hematol Oncol Clin North Am. 1990 Apr;4(2):389–404. [PubMed] [Google Scholar]
  13. Kloke O., Niederle N., Qiu J. Y., Wandl U., Moritz T., Nagel-Hiemke M., Hawig I., Opalka B., Seeber S., Becher R. Impact of interferon alpha-induced cytogenetic improvement on survival in chronic myelogenous leukaemia. Br J Haematol. 1993 Mar;83(3):399–403. doi: 10.1111/j.1365-2141.1993.tb04663.x. [DOI] [PubMed] [Google Scholar]
  14. Lilleyman J. S., Britton J. A., Anderson L. M., Richards S. M., Bailey C. C., Chessells J. M. Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia. J Clin Pathol. 1994 Aug;47(8):689–692. doi: 10.1136/jcp.47.8.689. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Lilleyman J. S., Hinchliffe R. F. Pre-B and 'common' lymphoblastic leukaemia of childhood compared. Br J Haematol. 1989 Feb;71(2):227–231. doi: 10.1111/j.1365-2141.1989.tb04259.x. [DOI] [PubMed] [Google Scholar]
  16. Lilleyman J. S., Potter A. M., Watmore A. E., Cooke P., Sokol R. J., Wood J. K. Myeloid karyotype and the malignant phase of chronic granulocytic leukaemia. Br J Haematol. 1978 Jul;39(3):317–323. doi: 10.1111/j.1365-2141.1978.tb01104.x. [DOI] [PubMed] [Google Scholar]
  17. Lithotripsy. Health and Public Policy Committee, American College of Physicians. Ann Intern Med. 1985 Oct;103(4):626–629. [PubMed] [Google Scholar]
  18. Matutes E., Catovsky D. The value of scoring systems for the diagnosis of biphenotypic leukemia and mature B-cell disorders. Leuk Lymphoma. 1994;13 (Suppl 1):11–14. doi: 10.3109/10428199409052666. [DOI] [PubMed] [Google Scholar]
  19. Murphy S. B., Bowman W. P., Abromowitch M., Mirro J., Ochs J., Rivera G., Pui C. H., Fairclough D., Berard C. W. Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol. 1986 Dec;4(12):1732–1739. doi: 10.1200/JCO.1986.4.12.1732. [DOI] [PubMed] [Google Scholar]
  20. Pedersen-Bjergaard J., Rowley J. D. The balanced and the unbalanced chromosome aberrations of acute myeloid leukemia may develop in different ways and may contribute differently to malignant transformation. Blood. 1994 May 15;83(10):2780–2786. [PubMed] [Google Scholar]
  21. Raimondi S. C. Current status of cytogenetic research in childhood acute lymphoblastic leukemia. Blood. 1993 May 1;81(9):2237–2251. [PubMed] [Google Scholar]
  22. Rivera G. K., Raimondi S. C., Hancock M. L., Behm F. G., Pui C. H., Abromowitch M., Mirro J., Jr, Ochs J. S., Look A. T., Williams D. L. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet. 1991 Jan 12;337(8733):61–66. doi: 10.1016/0140-6736(91)90733-6. [DOI] [PubMed] [Google Scholar]
  23. Roberts W. M., Rivera G. K., Raimondi S. C., Santana V. M., Sandlund J. T., Crist W. M., Pui C. H. Intensive chemotherapy for Philadelphia-chromosome-positive acute lymphoblastic leukaemia. Lancet. 1994 Feb 5;343(8893):331–332. doi: 10.1016/s0140-6736(94)91166-5. [DOI] [PubMed] [Google Scholar]
  24. Rubnitz J. E., Link M. P., Shuster J. J., Carroll A. J., Hakami N., Frankel L. S., Pullen D. J., Cleary M. L. Frequency and prognostic significance of HRX rearrangements in infant acute lymphoblastic leukemia: a Pediatric Oncology Group study. Blood. 1994 Jul 15;84(2):570–573. [PubMed] [Google Scholar]
  25. Scott A. A., Head D. R., Kopecky K. J., Appelbaum F. R., Theil K. S., Grever M. R., Chen I. M., Whittaker M. H., Griffith B. B., Licht J. D. HLA-DR-, CD33+, CD56+, CD16- myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French-American-British acute myeloid leukemia-M3. Blood. 1994 Jul 1;84(1):244–255. [PubMed] [Google Scholar]
  26. Scott C. S., Stark A. N., Limbert H. J., Master P. S., Head C., Roberts B. E. Diagnostic and prognostic factors in acute monocytic leukaemia: an analysis of 51 cases. Br J Haematol. 1988 Jun;69(2):247–252. doi: 10.1111/j.1365-2141.1988.tb07629.x. [DOI] [PubMed] [Google Scholar]
  27. Secker-Walker L. M. Prognostic and biological importance of chromosome findings in acute lymphoblastic leukemia. Cancer Genet Cytogenet. 1990 Oct 1;49(1):1–13. doi: 10.1016/0165-4608(90)90158-7. [DOI] [PubMed] [Google Scholar]
  28. Seymour J. F., Estey E. H. The prognostic significance of auer rods in myelodysplasia. Br J Haematol. 1993 Sep;85(1):67–76. doi: 10.1111/j.1365-2141.1993.tb08647.x. [DOI] [PubMed] [Google Scholar]
  29. Shepherd P. C., Ganesan T. S., Galton D. A. Haematological classification of the chronic myeloid leukaemias. Baillieres Clin Haematol. 1987 Dec;1(4):887–906. doi: 10.1016/s0950-3536(87)80031-8. [DOI] [PubMed] [Google Scholar]
  30. Spiers A. S., Bain B. J., Turner J. E. The peripheral blood in chronic granulocytic leukaemia. Study of 50 untreated Philadelphia-positive cases. Scand J Haematol. 1977 Jan;18(1):25–38. [PubMed] [Google Scholar]
  31. Stoll D. B., Peterson P., Exten R., Laszlo J., Pisciotta A. V., Ellis J. T., White P., Vaidya K., Bozdech M., Murphy S. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome. Am J Hematol. 1988 Feb;27(2):77–83. doi: 10.1002/ajh.2830270202. [DOI] [PubMed] [Google Scholar]
  32. Traweek S. T. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol. 1993 Apr;99(4):504–512. doi: 10.1093/ajcp/99.4.504. [DOI] [PubMed] [Google Scholar]
  33. Trueworthy R., Shuster J., Look T., Crist W., Borowitz M., Carroll A., Frankel L., Harris M., Wagner H., Haggard M. Ploidy of lymphoblasts is the strongest predictor of treatment outcome in B-progenitor cell acute lymphoblastic leukemia of childhood: a Pediatric Oncology Group study. J Clin Oncol. 1992 Apr;10(4):606–613. doi: 10.1200/JCO.1992.10.4.606. [DOI] [PubMed] [Google Scholar]
  34. Yam L. T., Yam C. F., Li C. Y. Eosinophilia in systemic mastocytosis. Am J Clin Pathol. 1980 Jan;73(1):48–54. doi: 10.1093/ajcp/73.1.48. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES